[1] 于艳秋,李昆,卢晓梅,等. 丹参诱导pаMHC-EGFP小鼠转基因胚胎干细胞向心肌细胞分化的作用[J]. 中国医科大学学报, 2007,36(2): 150-152. [2] 范英昌,华声瑜,姚雅娟. 丹酚酸B诱导体外培养大鼠骨髓基质细胞向心肌样细胞分化的研究[J]. 天津中医学院学报, 2005,24(1): 10-12. [3] Hu X, Yu SP, Fraser JL, et al. Transplantation of hypoxiapreconditioned mesenchymal stem cells improves infarcted heart hunction via enhanced survival of implanted cells and angiogenesis [J]. J Thorac Cardiovasc Surg, 2008, 135(4): 799-808. [4] Niagara MI, Haider HKh, Jiang S, et al. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart [J]. Circ Res, 2007, 100(4): 545-555. [5] Wisel S, Khan M, Kuppusamy ML, et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression [J]. J Pharmacol Exp Ther, 2009, 329(2): 543-550. [6] Hou JF, Zhang H, Yuan X, et al. In vitro effects of low-level laser irradiation for bone marrow mesenchymal stem cells: proliferation, growth factors secretion and myogenic differentiation [J]. Lasers Surg Med, 2008, 40(10): 726-733. [7] Bartunek J, Croissant JD, Wijns W, et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium [J]. Am J Physiol Heart Circ Physiol, 2007, 292(2): H1095-H1104. [8] Lu G, Haider HK, Jiang S, et al. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induce connexin-43 [J]. Circulation, 2009, 119(19): 2587-2596. |